Prevention of Human Papillomavirus (HPV) Infection in Paediatric Kidney and Liver Transplant Recipients and in Paediatric Patients With Advanced Chronic Kidney Disease
NCT ID: NCT03100682
Last Updated: 2021-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2017-03-18
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genital HPV Infections Before and After Renal Transplantation
NCT01717443
PApillomavirus in REnal Transplant Patient
NCT02845739
Ano-genital Human Papillomavirus (HPV) Infection, Precancerous Lesions and Genital Warts Among Danish Renal Transplant Recipients
NCT03018327
Vaccination Against COVID-19 in Chronic Kidney Disease
NCT04743947
Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study
NCT01471223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Paediatric patients with CKD
* Who receive HPV vaccination according to country-specific vaccine schedule
Exclusion Criteria
* No written informed consent
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Heidelberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PD Dr. med. Britta Hoecker
Privatdozentin Dr. med. Britta Hoecker
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Britta Hoecker, MD
Role: PRINCIPAL_INVESTIGATOR
University Children's Hospital of Heidelberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Children's Hospital
Heidelberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Britta Hoecker, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HPVaxResponse Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.